AAAAAA
Results: 51-66/66
Authors:
KESSLER DA
Citation: Da. Kessler, INTRODUCING MEDWATCH - A NEW APPROACH TO REPORTING MEDICATION AND DEVICE ADVERSE-EFFECTS AND PRODUCT PROBLEMS, Journal of nurse-midwifery, 39(6), 1994, pp. 402-407
Authors:
KESSLER DA
ROSE JL
TEMPLE RJ
SCHAPIRO R
GRIFFIN JP
Citation: Da. Kessler et al., THERAPEUTIC-CLASS WARS - DRUG PROMOTION IN A COMPETITIVE MARKETPLACE, The New England journal of medicine, 331(20), 1994, pp. 1350-1353
Authors:
KESSLER DA
Citation: Da. Kessler, REMARKS BY THE COMMISSIONER OF FOOD AND DRUGS, Food and drug law journal, 48(1), 1993, pp. 1-10
Authors:
KESSLER DA
LEVINE H
Citation: Da. Kessler et H. Levine, PATTERN-FORMATION IN DICTYOSTELIUM VIA THE DYNAMICS OF COOPERATIVE BIOLOGICAL ENTITIES, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 48(6), 1993, pp. 4801-4804
Authors:
ZOU XQ
LEVINE H
KESSLER DA
Citation: Xq. Zou et al., INTERACTION BETWEEN A DRIFTING SPIRAL AND DEFECTS, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 47(2), 1993, pp. 800-803
Authors:
KESSLER DA
Citation: Da. Kessler, CHANGING THE CULTURE OF MEDICINE - THE FDAS MEDWATCH PROGRAM, Academic medicine, 68(10), 1993, pp. 776-777
Authors:
KESSLER DA
Citation: Da. Kessler, MED WATCH - THE NEW FDA MEDICAL PRODUCTS REPORTING PROGRAM, Clinical pharmacy, 12(7), 1993, pp. 529-530
Authors:
KESSLER DA
MERKATZ RB
SCHAPIRO R
Citation: Da. Kessler et al., A CALL FOR HIGHER STANDARDS FOR BREAST IMPLANTS, JAMA, the journal of the American Medical Association, 270(21), 1993, pp. 2607-2608
Authors:
KESSLER DA
Citation: Da. Kessler, POSTMARKETING SURVEILLANCE - BEYOND MEDWATCH - REPLY, JAMA, the journal of the American Medical Association, 270(18), 1993, pp. 2180-2180
Authors:
ARCHER DE
KESSLER DA
Citation: De. Archer et Da. Kessler, FOODBORNE ILLNESS IN THE 1990S, JAMA, the journal of the American Medical Association, 269(21), 1993, pp. 2737-2737
Authors:
KESSLER DA
Citation: Da. Kessler, INTRODUCING MEDWATCH - A NEW APPROACH TO REPORTING MEDICATION AND DEVICE ADVERSE-EFFECTS AND PRODUCT PROBLEMS, JAMA, the journal of the American Medical Association, 269(21), 1993, pp. 2765-2768
Authors:
MERKATZ RB
TEMPLE R
SOBEL S
FEIDEN K
KESSLER DA
Citation: Rb. Merkatz et al., WOMEN IN CLINICAL-TRIALS OF NEW DRUGS - A CHANGE IN FOOD-AND-DRUG-ADMINISTRATION POLICY, The New England journal of medicine, 329(4), 1993, pp. 292-296
Authors:
KESSLER DA
MERKATZ RB
TEMPLE R
Citation: Da. Kessler et al., FDA POLICY ON WOMEN IN DRUG TRIALS - REPLY, The New England journal of medicine, 329(24), 1993, pp. 1815-1816
Authors:
KESSLER DA
SIEGEL JP
NOGUCHI PD
ZOON KC
FEIDEN KL
WOODCOCK J
Citation: Da. Kessler et al., REGULATION OF SOMATIC-CELL THERAPY AND GENE-THERAPY BY THE FOOD-AND-DRUG-ADMINISTRATION, The New England journal of medicine, 329(16), 1993, pp. 1169-1173
Authors:
KESSLER DA
Citation: Da. Kessler, INTEGRATING CALLS FOR SERVICE WITH COMMUNITY-ORIENTED AND PROBLEM-ORIENTED POLICING - A CASE-STUDY, Crime and delinquency, 39(4), 1993, pp. 485-508
Authors:
KESSLER DA
Citation: Da. Kessler, MEDWATCH - THE NEW FDA MEDICAL PRODUCTS REPORTING PROGRAM, American journal of hospital pharmacy, 50(6), 1993, pp. 1151-1152